A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

Not specified

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Post-Menopausal Osteopenia

Interventions

DRUG

ibandronate [Bonviva/Boniva]

150mg po monthly for 2 years

DRUG

Placebo

po monthly for 2 years

Trial Locations (4)

Toulouse

Saint-Priest-en-Jarez

Lyon

Paris

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00545207 - A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. | Biotech Hunter | Biotech Hunter